The blood-thinning drug PRADAXA has been linked to fatal internal bleeding and heart attacks. The FDA approved Pradaxa in October 2010 and it is manufactured by Boehringer Ingelheim Pharmaceuticals. P...
radaxa is used to treat atrial fibrillation, an irregular heartbeat that can increase a patient’s risk of stroke. A study published in the Archives of Internal Medicine in 2012 found that Pradaxa was “significantly associated with a higher risk” of heart attacks and acute coronary syndrome compared to the alternative wafarin.
Did you work on this visual? Claim credit!